The modernization will enable the company to accommodate innovative technologies and expand its research capabilities. Governor Youngkin met with Haleon leadership in London in July 2024 to discuss ...

Governor Glenn Youngkin announced on Monday that a global healthcare company will be expanding its research and development facility located in the City of Richmond.

The maker of Advil, Tums and Sensodyne toothpaste is investing $54.2 million to upgrade its global research and development ...

The consumer health company site will launch an internship program with the state government and Virginia Commonwealth University ...

Haleon, an international manufacturer of medicine, vitamins and toothpaste, will upgrade its lab in Richmond’s North Side at a cost of $54 million, the company announced Monday. Based in England ...

Haleon, a global company behind home healthcare products like Advil, Tums and Aquafresh, announced plans to upgrade its Richmond research and development facility.

The UK-based pharmaceutical company Haleon will invest $54.2 million to upgrade its R&D facility in Richmond, which has helped birth or grow products such as Advil, Emergen-C and Robitussin.

Tyler is tracking a very nice Tuesday afternoon.

Richmond is cementing its status as a hub for pharmaceutical innovation, with Gov. Glenn Youngkin dubbing the region a “pharma corridor” during Monday’s announcement of major investments and ...